Alpha-lactalbumin Vaccine ( Anixa Biosciences)

N/A

Report date: 2025/12/16 10:09:10

Base Information

Drug NameAlpha-lactalbumin Vaccine ( Anixa Biosciences)
Drug Alias NameaLA breast cancer vaccine (Case Comprehensive Cancer Center)α-lactalbumin vaccine (Case Comprehensive Cancer Center)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsNeoplasm, ResidualTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCleveland ClinicAnixa Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnixa Biosciences IncCase Comprehensive Cancer Center
Inactive CompaniesN/A
Active IndicationsNeoplasm, ResidualTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A